Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study
Amanda J Cox1, Fang-Chi Hsu2, Barry I Freedman3
1Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC.
Insights
Individuals with type 2 diabetes and high coronary artery calcification (CAC) face varying mortality risks. Modifiable cardiovascular disease (CVD) risk factors, including vascular calcification, significantly impact outcomes in this high-risk group.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Type 2 diabetes (T2D) and high coronary artery calcification (CAC) identify individuals at elevated cardiovascular disease (CVD) risk.
- Risk stratification within this high-risk cohort remains crucial for personalized management.
- Variability in adverse outcomes suggests other contributing factors beyond CAC alone.
Purpose of the Study:
- To investigate the association between modifiable cardiovascular disease (CVD) risk factors and all-cause mortality in individuals with type 2 diabetes (T2D) and high coronary artery calcification (CAC).
- To determine if traditional CVD risk factors provide additional prognostic information in a high-risk T2D population with CAC >1,000 mg.
Main Methods:
- A cohort of 371 European American individuals with T2D and CAC >1,000 mg from the Diabetes Heart Study (DHS) was followed for 8.2 ± 3.0 years.
- Cox proportional hazards regression models were employed to analyze all-cause mortality.
- Differences in CVD risk factors between survivors and non-survivors were compared.
Main Results:
- Higher vascular calcified plaque scores were significantly associated with increased mortality risk (HR 1.31-1.63).
- Elevated HbA1c, lipids, C-reactive protein, and reduced kidney function also correlated with increased mortality risk (HR 1.1-1.5).
- Deceased participants had longer T2D duration and lower use of cholesterol-lowering medications.
Conclusions:
- Vascular calcification and modifiable CVD risk factors offer valuable prognostic information for risk assessment in high-risk T2D patients.
- The use of cholesterol-lowering medication demonstrated a protective effect against mortality in this cohort.
Objective:
Not all individuals with type 2 diabetes and high coronary artery calcified plaque (CAC) experience the same risk for adverse outcomes. This study examined a subset of high-risk individuals based on CAC >1,000 mg (using a total mass score) and evaluated whether differences in a range of modifiable cardiovascular disease (CVD) risk factors provided further insights into risk for mortality.
Research Design And Methods:
We assessed contributors to all-cause mortality among 371 European American individuals with type 2 diabetes and CAC >1,000 from the Diabetes Heart Study (DHS) after 8.2 ± 3.0 years (mean ± SD) of follow-up. Differences in known CVD risk factors, including modifiable CVD risk factors, were compared between living (n = 218) and deceased (n = 153) participants. Cox proportional hazards regression models were used to quantify risk for all-cause mortality.
Results:
Deceased participants had a longer duration of type 2 diabetes (P = 0.02) and reduced use of cholesterol-lowering medications (P = 0.004). Adjusted analyses revealed that vascular calcified plaque scores were associated with increased risk for mortality (hazard ratio 1.31-1.63; 3.89 × 10(-5) < P < 0.03). Higher HbA1c, lipids, and C-reactive protein and reduced kidney function also were associated with a 1.1- to 1.5-fold increased risk for mortality (3.45 × 10(-6) < P < 0.03) after adjusting for confounding factors.
Conclusions:
Even in this high-risk group, vascular calcification and known CVD risk factors provide useful information for ongoing assessment. The use of cholesterol-lowering medication seemed to be protective for mortality.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetic Retinopathy
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology

